New Assessment System in Measuring Symptom Distress in Cancer Patients

This trial studies how well a new assessment system (MDASI or other MD Anderson-developed PRO instrument) works in measuring symptoms and the impact on quality of life in cancer patients. Development of a new assessment system may provide more information about the common symptoms that may occur in patients due to cancer and its treatment and how the symptoms impact quality of life.

Intervention

Interview, Quality-of-Life Assessment, Questionnaire Administration

Condition

Caregiver, Health Care Provider, Malignant Neoplasm, Physician

Investigators

Lori Williams

See list of participating sites